Development and validation of a circulating tumor DNA-based machine learning model for predicting immunotherapy response in non-small cell lung cancer
Year: 2025
Type: article
Language: en
Topic: Cancer Genomics and Diagnostics
Authors and affiliations:
raw_author_name: Ji Xia
raw_affiliation_strings: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China
raw_author_name: Tianchu He
raw_affiliation_strings: Department of Oncology, Qiandongnan Prefecture People's Hospital, Kaili, China
raw_author_name: Yong Hu
raw_affiliation_strings: Department of Oncology, Guiyang Pulmonary Hospital, Guiyang, China
raw_author_name: Daobin Zhou
raw_affiliation_strings: Department of Oncology, Qiandongnan Prefecture People's Hospital, Kaili, China
raw_author_name: Dan Zou
raw_affiliation_strings: Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China
raw_author_name: Ya Li
raw_affiliation_strings: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China
raw_author_name: Min Zhang
raw_affiliation_strings: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China
raw_author_name: Benlan Li
raw_affiliation_strings: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China
raw_author_name: Minfang Wang
raw_affiliation_strings: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China
raw_author_name: Xian Liu
raw_affiliation_strings: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China
raw_author_name: Zhongjun Huang
raw_affiliation_strings: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China
raw_author_name: Shengfa Su
raw_affiliation_strings: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Jie Peng
raw_affiliation_strings: Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China